Arkolith/Insider Trading/OKUR/Form 4

Saccomano Nicholas A

President and CEO, DirectorOnKure Therapeutics, Inc. (OKUR) · full profile →Form 4 · filed Mar 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$358
Net Open-Market Flow
-$358
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 23, 2026Sell(S)86$4.16$3587K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001609284-26-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML